304
Participants
Start Date
February 1, 2010
Primary Completion Date
April 13, 2023
Study Completion Date
April 13, 2023
Pembrolizumab
Pemetrexed
Cisplatin
Carboplatin
Collaborators (6)
AbbVie
INDUSTRY
Amgen
INDUSTRY
AstraZeneca
INDUSTRY
Bayer
INDUSTRY
Gilead Sciences
INDUSTRY
Janssen, LP
INDUSTRY
Pfizer
INDUSTRY
Aetion, Inc.
OTHER